AUTOLOGOUS iPS trial in Japan approved, with much fanfare. Japan has made a national priority of iPS and is already blasting away on a leadership path, here for macular degeneration.
http://lnkd.in/tYHqTy
AUTOLOGOUS iPS trial in Japan approved, with much fanfare. Japan has made a national priority of iPS and is already blasting away on a leadership path, here for macular degeneration.
http://lnkd.in/tYHqTy